• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

MassMedic: New England suited to be drug delivery device powerhouse

March 30, 2021 By Sean Whooley

MassMedicThe Massachusetts Medical Device Industry Council (MassMedic) believes New England is capable of growing in the drug delivery device space.

In a recently published report written by Alira Health’s Aude Ouesanga, Laure Girard and Marie Vaillant and shared by MassMedic, a shift in the space was highlighted in terms of devices enabling therapeutic delivery to actually having an impact on the performance of the drug. The addition of connectivity capabilities in digital health ecosystems offers more in terms of monitoring and data collection, too.

According to the report, significant progress in drug delivery device research in recent years has been driven by advancements in the pharmaceutical industry, as well as in biomedical research and material sciences. With a variety of organizations across New England offering capabilities in these areas, there is an opportunity for growth.

The fact that New England is home to a number of prestigious universities that include specialized programs that support development and innovation for the space, including UMass, MIT, WPI, UConn, Northeastern, Western New England College and more, is a massive boost, too.

MassMedic said more than 300 medical device companies can be found along the I-91 stretch that ranges through Connecticut and western Massachusetts, all with access to Boston and New York and the organizations, universities and hospitals across the area. A history of precision manufacturing and higher education offerings only add to the wealth of options at the disposal of drug delivery device makers.

“With more than 1,100 pharma, biotech and medical device companies, New England is uniquely suited to be a powerhouse in the evolving drug-delivery device industry,” MassMedic president Brian Johnson wrote in an email newsletter.

Filed Under: Business/Financial News, Drug-Device Combinations, Featured Tagged With: Alira Health, massmedic

IN CASE YOU MISSED IT

  • Elixir Medical reports sustained durability with bioadaptor compared to Medtronic stent
  • Senseonics closes public offering, private placement with Abbott
  • Embecta eyes shift from insulin delivery to broader medical supplies focus
  • Medtronic earns expanded CE mark for Prevail paclitaxel-coated balloon
  • Sequel Med Tech to pair automated insulin delivery system with Abbott’s future dual glucose-ketone sensor

About Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at swhooley@wtwhmedia.com.

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS